Innovation in over-the-counter (OTC) drug access is emerging as a potential way to ease longstanding challenges in obtaining treatment across the US. In a new publication, Managing Director Chris Stomberg examines how expanding the availability of some medications without a prescription may help patients who face persistent barriers to care. 
 
Dr. Stomberg’s analysis reviews patterns in healthcare access, the regulatory considerations that shape OTC decision-making, and recent developments that could support broader use of the OTC pathway. The study also considers the role different retail channels may play in improving access for underserved communities. The publication identifies factors that may help manufacturers, retailers, and policymakers evaluating future opportunities to expand treatment availability.